Kisunla 350 mg/20 mL (17.5 mg/mL) injection Images
Generic Name: donanemab
This medication has been identified as Kisunla 350 mg/20 mL (17.5 mg/mL) injection. It is supplied by Eli Lilly and Company.
Kisunla is used in the treatment of Alzheimer's Disease and belongs to the drug class miscellaneous central nervous system agents. Kisunla 350 mg/20 mL (17.5 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Kisunla
- Generic Name
- donanemab
- Strength
- 350 mg/20 mL (17.5 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous central nervous system agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eli Lilly and Company
- National Drug Code (NDC)
- 00002-9401
More about Kisunla (donanemab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous central nervous system agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.